Lataa...
Antibody–Drug Conjugates for Cancer Therapy
Antibody–drug conjugates (ADCs) take advantage of the specificity of a monoclonal antibody to deliver a linked cytotoxic agent directly into a tumour cell. The development of these compounds provides exciting opportunities for improvements in patient care. Here, we review the key issues impacting on...
Tallennettuna:
| Julkaisussa: | Biomedicines |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
MDPI
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5344263/ https://ncbi.nlm.nih.gov/pubmed/28536381 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/biomedicines4030014 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|